Publication: The Anthrax Vaccine Immunization Program: History, Controversy and Legal Issues
No Thumbnail Available
Open/View Files
Date
2000
Authors
Published Version
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
The Anthrax Vaccine Immunization Program: History, Controversy and Legal Issues (2000 Third Year Paper)
Research Data
Abstract
This paper documents the issues that make the AVIP so controversial. It summarizes the current knowledge about the safety and efficacy of the anthrax vaccine, including the vaccine manufacturer’s history with FDA regulators. It summarizes the analysis that led DoD to balance the risks and benefits of the anthrax vaccine in favor of universal, mandatory vaccination. It includes a description of DoD efforts to achieve successful implementation of the program, as well as the setbacks that have arisen. This collection of observations about the Anthrax Vaccine Immunization Program is relevant for: any attorney prosecuting or defending a member accused of refusing the vaccine; for any servicemember concerned about taking the vaccine; and for member of the general public who wants to know the context of the current controversy.
Description
Other Available Sources
Keywords
Food and Drug Law, AVIP, anthrax
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service